BRIEF—Merck KGaA spending additional 14 million euros in China

Germany’s Merck KGaA says it has expanded its M Lab Collaboration Center in Shanghai, the company’s largest in its global network of 10 interconnected labs.

The 14 million-euro ($15.5 million) investment adds a new biology application lab, a process development training center and an upstream application lab to the existing M Lab Collaboration Center in Shanghai, Merck noted.

“With the evolving needs of the biopharmaceutical industry in China and greater emphasis on novel drug therapies, we see growing demands in process development applications and talent development in the region,” said Dr Roy Wu, managing director of the Life Science business sector, Merck China.

Opened in 2020 and strategically located in Pudong, at the heart of the biomedical park in Shanghai, the M Lab Collaboration Center offers customizable solutions tailored for China’s life science community to help advance drug development.